Enjoy a helping of recent science news!
ARTIFICIAL INTELLIGENCE
China’s Fudan Hospital implants world’s first commercial BCI chip in patient | DongA Science Chinese medical staff have successfully implanted a brain–computer interface (BCI) that has received full commercial approval into a patient with spinal cord injury. The device reads brain signals and converts them into hand movements, leading to assessments that China has taken a step ahead of the United States in the race to commercialize BCIs.
The Pentagon's new AI playbook treats slow adoption as a bigger risk than imperfect alignment | The Decoder The Department of the Navy, which oversees both the Navy and the Marine Corps, has formally approved a new "Strategy to Weaponize Data and Artificial Intelligence."
AI in Drug Discovery: Target ID to Clinical Translation | Drug Discovery News AI is now embedded across the drug discovery pipeline. This guide maps the full arc, where the technology delivers, where it still falls short, and what the science actually shows.
Lab-grown sperm: scientists inch closer to fertility breakthrough | Nature It sounds like science fiction: collecting a person’s blood cells, engineering them so they eventually transform into immature sperm, and then incubating them in a tiny pouch grown on a mouse’s kidney.
A vitamin A discovery is changing what scientists know about vision | ScienceDaily Instead of blue cone cells migrating away from the retina's center, the study found they transform into red and green cones under the influence of vitamin A-related signals and thyroid hormones.
Patients may enjoy the convenience of automated texting while cursing its curtness
A robot that reads bacteria by touch, without staining or chemical labels | Phys.org A research team led by Prof. Zong-Hong Lin at National Taiwan University has developed a robotic sensing platform that identifies bacteria through touch.
Beckman Coulter’s Alzheimer’s blood test obtains CE mark - Medical Device Network | Medicaldevice-Network.com Beckman Coulter's assay measures phosphorylated pTau217 levels in blood. Beckman Coulter Diagnostics has secured a CE mark for a blood test to aid in the clinical evaluation of amyloid pathology under the European Union’s in vitro diagnostic regulation (EU IVDR).
How to avoid dementia — what the science really says | Nature Offshoots of the FINGER study in the Netherlands and in 12 Latin American countries, will announce their results this month, and the World Health Organization will release its new dementia risk-reduction guidelines on 16 July. Deciphering the most effective ways to cut risks is important for researchers, clinicians and the public alike — especially given that the number of people with dementia worldwide is expected to soar in decades to come.
